VeriScience Inc.
Presenter: Pratibha Chaturvedi, President
Company Information
Company Type: Services
Development Stage: Private
Company Profile
VeriScience provides fully integrated product development services to biotech companies looking for a cost effective novel approach to their pipeline development strategies. By providing companies with an experienced team of collaborative experts, VeriScience is able to guide companies through tough protocol development decisions while conforming to strict regulation hurdles resulting in a cost effective, timely and efficient pre-clinical or clinical trial. The sourcing of experienced knowledgeable commercialization experts who work well together has been accomplished. This provides Biotech Companies, Venture Capitalists, Investment Bankers and Government Institutions the ability to reduce their risk in investment decisions by having an independent third party analyze the merits of the drug candidate or medical device, provide the correct bio markers and milestones to increase acceptance by Regulatory Agencies, and provide recommendations on further development activities.
Our services include pre-clinical product development, IP valuation, product evaluation and feasibility, data validation and project management. We provide medical writing including SOPs, pre-clinical and clinical protocol development, IND submission packages, data analysis and report writing. VeriScience has current strategic alliances with CROs for clinical and pre-clinical studies and will negotiate and manage CRO's and collaborations to provide seamless completion of projects. Our operations provide standard turnaround times to increase planning capabilities for data receipt and decision making. Input from VeriScience will clarify any current technical questions and concerns about your project.
As an added value to our clients we are able to offer clinical trials in India, Africa and Asia Pacific in full compliance with FDA/ICH regulations from Phase I IV. The principals of VeriScience understand the complexities of the different cultures and have developed invaluable relationships with CROs throughout these regions. VeriScience and its partners can take your compound from pre-clinical development to proof of concept in the most timely, cost effective manner. For those clients who choose to outsource to India, but are not comfortable dealing with the CROs directly, VeriScience can manage your clinical trials and be the point of contact for you, in turn delivering significant cost savings.
VeriSciences in-depth knowledge of Indias biotech commercialization industry allows clinical trials to be performed with reduced overall foreign risk while enjoying the benefits of a very cost effective clinical trial that will pass Canadian and US regulation requirements.
Presenter Bio
Dr Pratibha Chaturvedi founded VeriScience Inc. with Dr Rinee Mukherjee in 2006 to provide product development services to emerging biotech companies. Dr. Chaturvedi has a Ph.D. in Immunology and received post doctoral training from the University of Western Ontario. She has worked as Scientific Director, CRO Division for KGK Synergize of London, designing, developing and implementing pre-clinical and clinical trials and was the Senior Scientist for Diabetogen Bioscience Inc. Dr Chaturvedi's key areas of experience include, immunology, monoclonal antibodies, cancer, type 2 diabetes, small molecule based therapies, autoimmune diseases and inflammation.
Contact
VeriScience Inc.
70 Sunnyside Dr., Suite 40
London
ON, Canada
N5X 3W5
ph: 519-434-8710
fx: 519-434-2981
www.verscience.ca
pratibhac@veriscience.ca